(Q33396120)

English

Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

multicenter clinical trial

0 references

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

object named as

Anna Turkina

2

0 references

author name string

Franck E Nicolini

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zhi-Xiang Shen

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Neil Gallagher

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Saengsuree Jootar

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bayard L Powell

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Carmino De Souza

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ming Zheng

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Tomasz Szczudlo

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Philipp le Coutre

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

5 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

118-126

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

Chronic myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

AMN107: tightening the grip of imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26249

21 January 2018

Identifiers

10.1002/CNCR.26249

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33396120&oldid=1599496479"